Cell adhesion and tissue factor upregulation in oxygenators used during coronary artery bypass grafting are modified by the corline heparin surface

Scandinavian Cardiovascular Journal

Volumn 36, Issue 6, 2002, Pages 351-357

  Johnell, M ^a   Elgue, G ^a   Thelin, S ^a   Larsson, R ^a   Siegbahn, A ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CABG; Heparin; Leukocyte; Tissue factor

Indexed keywords

CD11B ANTIGEN; HEPARIN; MESSENGER RNA; THROMBOPLASTIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CELL ACTIVATION; CELL ADHESION; CELL COUNT; CELL SURFACE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEVICE; EXTRACORPOREAL CIRCULATION; FEMALE; GRANULOCYTE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MATERIAL COATING; MONOCYTE; OXYGENATOR; PRIORITY JOURNAL; THROMBOCYTE ADHESION; UPREGULATION;

AGED; ANALYSIS OF VARIANCE; ANTICOAGULANTS; ANTIGENS, CD11B; CARDIOPULMONARY BYPASS; CELL ADHESION; COMPUTER GRAPHICS; CORONARY ARTERY BYPASS; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; OXYGENATORS, MEMBRANE; STATISTICS, NONPARAMETRIC; THROMBOPLASTIN; UP-REGULATION;

EID: 12244249164     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/140174302762659076     Document Type: Article

References (21)

1. Nydegger U, Rieben R, Lammle B. Biocompatibility in transfusion medicine. Transfus Sci 1996; 17(4): 481-488.
2. Tang L, Eaton JW. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med 1993; 178(6): 2147-2156.
3. Wendel HP, Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 1999; 16(3): 342-350.
4. Larm O, Larsson R, Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater Med Devices Artif Organs 1983; 11(2-3): 161-173.
5. Johnell Elgue G, Larsson R, Larsson A, Thelin S, Siegbahn A. Coagulation, fibrinolysis and cell activation in patients and shed blood during coronary artery bypass grafting using a new heparin-coated surface. J Thorac Cardiovasc Surg 2002 Aug; 124(2): 321-32.
6. Fan ST, Edgington TS. Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest 1991; 87(1): 50-57.
7. Kappelmayer J, Bernabei A, Edmunds LH Jr, Edgington TS, Colman RW. Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ Res 1993; 72(5): 1075-1081.
8. Barstad RM, Hamers MJ, Moller AS, Sakariassen KS. Monocyte procoagulant activity induced by adherence to an artificial surface is reduced by end-point immobilized heparin-coating of the surface. Thromb Haemost 1998; 79(2): 302-305.
9. Barstad RM, Ovrum E, Ringdal MA, et al. Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit. Br J Haematol 1996; 94(3): 517-525.
10. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning; A laboratory manual. Vols I-III. 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989.
11. Tenno T, Botling J, Oberg F, Jossan S, Nilsson K, Siegbahn A. The role of RAR and RXR activation in retinoid-induced tissue factor suppression. Leukemia 2000; 14(6): 1105-1111.
12. El Habbal MH, Smith L, Elliott MJ, Strobel S. Effect of heparin anticoagulation on neutrophil adhesion molecules and release of IL8: C3 is not essential. Cardiovasc Res 1995; 30(5): 676-681.
13. Nelson RM, Cecconi O, Roberts WG, Aruffo A, Linhardt RJ, Bevilacqua MP. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood 1993; 82(11): 3253-3258.
14. Peter K, Schwarz M, Conradt C, et al. Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation 1999; 100(14): 1533-1539.
15. Ernofsson M, Thelin S, Siegbahn A. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: A clinical study. J Thorac Cardiovasc Surg 1997; 113(3): 576-584.
16. Parratt R, Hunt BJ. Direct activation of factor X by monocytes occurs during cardiopulmonary bypass. Br J Haematol 1998; 101(1): 40-46.
17. Amirkhosravi A, Alexander M, May K, et al. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemost 1996; 75(1): 87-95.
18. Celi A, Pellegrini G, Lorenzet R, et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 1994; 91(19): 8767-8771.
19. Ernofsson M, Siegbahn A. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. Thromb Res 1996; 83(4): 307-320.
20. Lindmark E, Tenno T, Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 2000; 20(10): 2322-2328.
21. Niimi Y, Ichinose F, Ishiguro Y, et al. The effects of heparin coating of oxygenator fibers on platelet adhesion and protein adsorption. Anesth Analg 1999; 89(3): 573-579.